govx reminds me of nnvc. Both working on same boatload of stuff, at about same level of development only nnvc market cap 10x or so of govx. True much waiting is involved but govx ridiculously cheap. Only my opinion however.
Right Gambler, also McNally has communicated that that they are in discussion with the (NIH) for support for upcoming phase3 trials, at which time they would attract licensing agreements!
News 
Market Data 
Discover 
